Exoskeleton Training on Balance Control and Turning in Ambulation in Individuals With Incomplete Spinal Cord Injury

NCT06971510 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-05-14

No results posted yet for this study

Summary

This study investigates the impact of exoskeleton training on individuals with incomplete spinal cord injury (iSCI). Investigators focus on assessing how the use of the exoskeleton influences balance control and turning during ambulation and quality of life in this population. The study mainly involves interventions with participants utilizing exoskeleton devices to explore the influence on mobility, stability, and neuroplasticity, providing new insights into the potential benefits of exoskeleton training for individuals with incomplete spinal cord injuries.

Conditions

  • Spinal Cord Injuries

Interventions

DEVICE

Exoskeleton Training

Using EksoNR to train balance control and walking and turning abilities in patients with incomplete spinal cord injury.

OTHER

Conventional Physical Therapy

Using conventional physical therapy methods to train the balance control and walking and turning abilities in patients with incomplete spinal cord injury.

Sponsors & Collaborators

  • The Affiliated BenQ Hospital of Nanjing Medical University

    collaborator UNKNOWN
  • Hong Kong Metropolitan University

    lead OTHER

Principal Investigators

  • William WN Tsang, PhD · Department of Physiotherapy, School of Nursing and Health Studies, Hong Kong Metropolitan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06971510 on ClinicalTrials.gov